smallAccCompHo_0921.xslt
Company Registration No. 16357563 (England and Wales)
BIOFYNDER LIMITED
Financial Statements
for the Period from 01 April 2025 to 30 April 2026

BIOFYNDER LIMITED

Financial Statements for the period ending 30 April 2026

CONTENTS PAGE
Company Information 2
Statement of Financial Position 3
Notes to the Accounts 4
- 1 -

BIOFYNDER LIMITED

Financial Statements for the period ending 30 April 2026

Company Information

Company Details
Company Number 16357563
Registered Office LAB 4, FIRST FLOOR EPSILON HOUSE
ENTERPRISE ROAD, CHILWORTH
SOUTHAMPTON
SO16 7NS
Directors
Directors who held office during the period were:
HE, Peijun, Dr   
Jingyang SUN   
- 2 -

BIOFYNDER LIMITED

Financial Statements for the period ending 30 April 2026

Statement of Financial Position

12345678910
Notes 2026
£ £
Fixed Assets
Investments 5 978 -
Current Assets
Debtors due 1,805 -
Cash at bank and in hand 7,603 -
9,408 -
Creditors
Amount falling due within one year (40,494) -
Net Current Assets (31,086) -
Total Assets less current liabilities (30,108) -
Net Assets (30,108) -
Capital and Reserves
Called up Share Capital 10 -
Retained earnings at end of year (30,118) -
Shareholder funds (30,108) -
For the year ending 30/04/2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities.
Approved by the Board on 13 August 2026
Peijun He, Director
Company Registration No. 16357563
- 3 -

BIOFYNDER LIMITED

Financial Statements for the period ending 30 April 2026

Notes to the Accounts

1. Statutory Information
BIOFYNDER LIMITED is a private company, limited by shares, registered in England and Wales, registration number 16357563.
2. Accounting Policies
Basis of preparing the Financial Statements
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities.The financial statements have been prepared under the historical cost convention, in sterling, which is the functional currency of the company. The company is entitled to exemption from preparing group accounts as the group qualifies as a small group.
Presentation Currency
The accounts are presented in £ sterling.
Turnover
Turnover represents amounts receivable for goods and services supplied in the ordinary course of business, net of discounts and sales taxes. Revenue is recognised when control of the goods or services passes to the customer.
- 4 -

BIOFYNDER LIMITED

Financial Statements for the period ending 30 April 2026

Notes to the Accounts

Current Tax
Current tax is recognised based on taxable profit for the period using tax rates enacted or substantively enacted at the reporting date. No Corporation Tax is payable for the period because the company incurred taxable trading losses.
- 5 -

BIOFYNDER LIMITED

Financial Statements for the period ending 30 April 2026

Notes to the Accounts

Stock
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined on a first-in, first-out basis. The company held no stock at the reporting date.
Deferred Tax
Deferred tax is recognised in respect of timing differences at rates expected to apply when they reverse. No deferred tax asset has been recognised in respect of tax losses because recovery is not considered sufficiently certain.
- 6 -

BIOFYNDER LIMITED

Financial Statements for the period ending 30 April 2026

Notes to the Accounts

3. Employees
Average number of employees, including directors, during the year was as follows:
2026 2
4. Principal Activity
The principal activity of the company during the period was the international trading and distribution of medical diagnostic products and related regulatory and commercial services.
- 7 -

BIOFYNDER LIMITED

Financial Statements for the period ending 30 April 2026

Notes to the Accounts

5. Investments
Investments in Subsidiaries Other Investments - Listed Other Investments -Unlisted Total
£ £ £ £
Valuation at 01/04/2025 - - - -
Additions 978 - - 978
Disposals - - - -
Adjustments - - - -
Valuation at 30/04/2026 978 - - 978
- 8 -